Geron (GERN) Change in Inventory (2024 - 2026)
Geron (GERN) posted Change in Inventory of $16.7 million for Q1 2026, down 21.51% sequentially from $21.2 million in Q4 2025, and down 4.89% YoY from $17.5 million in Q1 2025.
Geron (GERN) Change in Inventory (2024 - 2026) Analysis & Trends
Geron has reported Change in Inventory for 3 years, with the latest figure at $16.7 million in Q1 2026.
- Quarterly Change in Inventory fell 4.89% year-over-year to $16.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $77.1 million (up 38.91% YoY) and the FY2025 annual result came in at $77.9 million, up 105.21% from the prior year.
- Change in Inventory retreated to $16.7 million in Q1 2026 per GERN's latest filing, from $21.2 million in the prior quarter.
- Over five years, Change in Inventory peaked at $26.3 million in Q3 2025 and troughed at $774000.0 in Q2 2024.
- A 3-year average of $16.6 million and a median of $17.6 million in 2024 frame the typical range for Change in Inventory.
- The sharpest annual moves came in 2025 and 2026: Change in Inventory jumped 1566.93% in 2025, then decreased 4.89% in 2026.
- Over 3 years, Change in Inventory stood at $17.7 million in 2024, then gained by 19.93% to $21.2 million in 2025, then retreated by 21.51% to $16.7 million in 2026.
- According to Business Quant data, Change in Inventory over the past three periods registered $16.7 million, $21.2 million, and $26.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 132.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 47.15 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -280,000.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 135.26 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 12.97 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Geron | 1.02 Mn | -299.83 Mn | - | -3.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.35 Mn |
| Jun 30, 2026 | -3.35 Mn |
| Mar 31, 2026 | 16.65 Mn |
| Mar 31, 2026 | 16.65 Mn |
| Dec 31, 2025 | 21.21 Mn |
| Dec 31, 2025 | 21.21 Mn |
| Sep 30, 2025 | 26.30 Mn |
| Sep 30, 2025 | 26.30 Mn |
| Jun 30, 2025 | 12.90 Mn |
| Jun 30, 2025 | 12.90 Mn |
| Mar 31, 2025 | 17.51 Mn |
| Mar 31, 2025 | 17.51 Mn |
| Dec 31, 2024 | 17.69 Mn |
| Dec 31, 2024 | 17.69 Mn |
| Sep 30, 2024 | 19.51 Mn |
| Sep 30, 2024 | 19.51 Mn |
| Jun 30, 2024 | 774,000.00 |
| Jun 30, 2024 | 774,000.00 |